HOME   |    PDF   |   


Title

Oral health considerations in patients receiving antidepressant therapy: Clinical implications and management strategies

 

Authors

Pihu Jamwal1, P.K. Monika2,*, Aditi Pustake3, Nisha Dholakiya4, Roshani Shrestha5 & Ketki Joshi6

 

Affiliation

1Department of Dentistry, Institute of Dental Sciences, Jammu & Kashmir, India; 2Department of Prosthodontics, Lenora Institute of Dental Sciences, Rajahmundry, Andhra Pradesh, India; 3Department of Dentistry, Sharad Pawar Dental College and Hospital, Sawangi (Meghe), Wardha, Maharashtra, India; 4Department of Dentistry, College of Dental Science and Research Center, Gujarat, India; 5Department of Dentistry, Nepal Medical College and Teaching Hospital, Gokarneshwar, Kathmandu, Nepal; 6Department of Dentistry, Tatyasaheb Kore Dental College and Research Center, Maharashtra, India; *Corresponding author

 

Email

Pihu Jamwal -E-mail: Pihujamwal98@gmail.com P.K.

Monika - E-mail: drmonikapenumallu@gmail.com

Aditi Pustake - E-mail: draditilakhe@gmail.com

 Nisha Dholakiya - E-mail: Nisha_dholakiya@yahoo.com

Roshani Shrestha - E-mail: roshnishrestha07@gmail.com

Ketki Joshi - E-mail: drketkijoshi@gmail.com

 

Article Type

Research Article

 

Date

Received February 1, 2026; Revised February 28, 2026; Accepted February 28, 2026, Published February 28, 2026

 

Abstract

Patients receiving antidepressant therapy frequently present with oral health complications that are under recognized and inadequately addressed in routine dental practice. Antidepressant medications-particularly selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)-are widely prescribed and have significant implications for oral health. Their adverse effects include xerostomia, increased caries risk, periodontal disease and bruxism and delayed wound healing, while depression itself may contribute to poor oral hygiene practices and irregular dental attendance. Additionally, pharmacologic interactions with vasoconstrictors, analgesics, antibiotics and antifungals can complicate dental management, particularly in medically compromised and geriatric patients. This review integrates pharmacologic, behavioral and clinical considerations related to antidepressant use and translates existing evidence into practical strategies for comprehensive dental management, thereby providing a clinically relevant framework for dental practitioners.

 

Keywords

Antidepressants, xerostomia, dental caries, periodontal disease, oral health management

 

Citation

Jamwal et al. Bioinformation 22(2): 1046-1050 (2026)

 

Edited by

Neelam Goyal & Shruti Dabi

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.